{"disease":{"id":"tinea-pedis","name":"Tinea pedis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":24,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"econazole-nitrate","indication_name":"Interdigital tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ECONAZOLE NITRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"naftifine","indication_name":"Interdigital tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"clotrimazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-dipropionate","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprolene","generic_name":"BETAMETHASONE DIPROPIONATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":51,"revenue":null,"mechanism":"Diprolene works by binding to the glucocorticoid receptor in the skin, which reduces inflammation and suppresses the immune system."},{"drug_id":"sulconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelderm","generic_name":"SULCONAZOLE","company_name":"Journey","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19","drug_class":"Azole Antifungal","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"butenafine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mentax","generic_name":"BUTENAFINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Benzylamine Antifungal","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"naftifine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"hydrocortisone","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clioquinol","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cliquinol","generic_name":"CLIOQUINOL","company_name":"","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"econazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spectazole","generic_name":"ECONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"Azole Antifungal","quality_score":48,"revenue":null,"mechanism":"Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes."},{"drug_id":"miconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ketoconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nizoral","generic_name":"ketoconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","drug_class":"Azole Antifungal [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"haloprogin","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HALOPROGIN","company_name":"Westwood Squibb","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"haloprogin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"luliconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luzu","generic_name":"LULICONAZOLE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Luzu works by inhibiting the growth of fungi by targeting a specific enzyme."},{"drug_id":"betamethasone","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"ciclopirox","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loprox","generic_name":"CICLOPIROX","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 1","drug_class":"ciclopirox","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pramocaine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"penlac","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Penlac","company_name":"9305-9954 Quebec Inc","drug_phase":"phase_2","molecular_target":"Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":26,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02335255","title":"Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1519,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03129321","title":"Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":876,"lead_sponsor_name":"Mylan Inc.","has_results":true},{"nct_id":"NCT03824912","title":"Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":831,"lead_sponsor_name":"Encube Ethicals Pvt. Ltd.","has_results":true},{"nct_id":"NCT04203342","title":"A Therapeutic Equivalence Study of Ketoconazole Cream 2%","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":682,"lead_sponsor_name":"Douglas Pharmaceuticals America Ltd","has_results":false},{"nct_id":"NCT03320486","title":"Non-inferiority Trial of Dapaconazole Versus Ketoconazole","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Biolab Sanus Farmaceutica","has_results":false},{"nct_id":"NCT03897257","title":"A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07056660","title":"Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Shenyang Medical College","has_results":false},{"nct_id":"NCT04883593","title":"A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT06869681","title":"Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT03135912","title":"Three-Arm Trial of Novel Treatment for Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"South End Skin Care","has_results":false},{"nct_id":"NCT03676686","title":"Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Natumin Pharma AB","has_results":false},{"nct_id":"NCT03999437","title":"SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"United Laboratories","has_results":false},{"nct_id":"NCT05363449","title":"Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04315051","title":"A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":39,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT02767271","title":"Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT04265521","title":"Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Biocool AB","has_results":false},{"nct_id":"NCT05493488","title":"A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT02394340","title":"Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT02871011","title":"Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Nitric Solutions Inc.","has_results":true},{"nct_id":"NCT04152226","title":"A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"DermBiont, Inc.","has_results":true}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}